Home
Chimeric Therapeutics (ASX:CHM) - Webinar Presentation
PUBLISHED
2024-03-01
Content
Jennifer Chow - CEO & Managing Director - Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
Author
Name | Finance News Network |